Free Trial
→ We recommended Palantir in 2021, now we’re recommending this... (From Behind the Markets) (Ad) Free ADCT Stock Alerts

ADC Therapeutics (ADCT) SEC Filings & 10K Form

ADC Therapeutics logo
$1.82 +0.07 (+3.71%)
As of 01/17/2025 03:59 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.
Compare

Recent ADC Therapeutics SEC Filings

Export to Excel
DateFilerForm TypeView
01/13/2025
11:20 AM		ADC Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/13/2024
8:00 PM		ADC Therapeutics (Issuer)
Green Jeremy (Reporting)
RedCo II Master Fund, L.P. (Reporting)
Redmile Group, LLC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/09/2024
7:37 PM		ADC Therapeutics (Issuer)
Carmona Jose (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/09/2024
7:39 PM		ADC Therapeutics (Issuer)
Kallebo Lisa Michelle (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/09/2024
7:42 PM		ADC Therapeutics (Issuer)
Zaki Mohamed (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/09/2024
7:35 PM		ADC Therapeutics (Issuer)
GRAHAM PETER J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/09/2024
7:30 PM		ADC Therapeutics (Issuer)
MALLIK AMEET (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/06/2024
8:00 PM		ADC Therapeutics (Issuer)
Green Jeremy (Reporting)
RedCo II Master Fund, L.P. (Reporting)
Redmile Group, LLC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/14/2024
8:00 PM		ADC Therapeutics (Subject)
Redmile Group, LLC (Filed by)
Form SC 13G/A
11/13/2024
3:13 PM		ADC Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/13/2024
7:58 AM		ADC Therapeutics (Subject)
Prosight Management, LP (Filed by)
Form SC 13G/A
11/13/2024
7:30 AM		ADC Therapeutics (Subject)
Prosight Management, LP (Filed by)
Form SC 13G/A
11/07/2024
9:44 AM		ADC Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/07/2024
6:54 AM		ADC Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/23/2024
3:35 PM		ADC Therapeutics (Filer)
Form DEF 14A
09/23/2024
3:39 PM		ADC Therapeutics (Filer)
Form DEFA14A
08/13/2024
11:15 PM		ADC Therapeutics (Filer)
Form EFFECT
08/06/2024
3:26 PM		ADC Therapeutics (Filer)
Form S-3
Registration statement under Securities Act of 1933  
08/06/2024
9:06 AM		ADC Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/06/2024
6:37 AM		ADC Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/03/2024
7:00 PM		ADC Therapeutics (Issuer)
Green Jeremy (Reporting)
RedCo II Master Fund, L.P. (Reporting)
Redmile Group, LLC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2024
8:40 PM		ADC Therapeutics (Issuer)
Monges Viviane (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2024
8:41 PM		ADC Therapeutics (Issuer)
Hug Peter (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2024
8:43 PM		ADC Therapeutics (Issuer)
BIZZARI JEAN-PIERRE (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2024
8:45 PM		ADC Therapeutics (Issuer)
Azelby Robert (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2024
8:29 PM		ADC Therapeutics (Subject)
Azelby Robert (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/18/2024
8:30 PM		ADC Therapeutics (Subject)
Squarer Ron (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/18/2024
8:35 PM		ADC Therapeutics (Issuer)
Squarer Ron (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2024
8:37 PM		ADC Therapeutics (Issuer)
Sandor Victor (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2024
8:38 PM		ADC Therapeutics (Issuer)
Pfisterer Thomas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2024
8:26 PM		ADC Therapeutics (Subject)
BIZZARI JEAN-PIERRE (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/18/2024
8:28 PM		ADC Therapeutics (Subject)
Sandor Victor (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/14/2024
4:44 PM		ADC Therapeutics (Issuer)
BIZZARI JEAN-PIERRE (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2024
4:46 PM		ADC Therapeutics (Issuer)
Azelby Robert (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2024
4:37 PM		ADC Therapeutics (Issuer)
Pfisterer Thomas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2024
4:40 PM		ADC Therapeutics (Issuer)
Hug Peter (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2024
4:23 PM		ADC Therapeutics (Issuer)
Monges Viviane (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2024
4:25 PM		ADC Therapeutics (Issuer)
Squarer Ron (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2024
4:29 PM		ADC Therapeutics (Issuer)
Sandor Victor (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/06/2024
2:33 PM		ADC Therapeutics (Issuer)
Pfisterer Thomas (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
05/14/2024
11:32 AM		ADC Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/09/2024
3:06 PM		ADC Therapeutics (Issuer)
MALLIK AMEET (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/07/2024
3:06 PM		ADC Therapeutics (Subject)
MALLIK AMEET (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/06/2024
5:51 AM		ADC Therapeutics (Filer)
Form 424B5
05/06/2024
5:38 AM		ADC Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/06/2024
5:29 AM		ADC Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/03/2024
8:31 PM		ADC Therapeutics (Subject)
Oaktree Capital Group Holdings GP, LLC (Filed by)
Form SC 13G
04/26/2024
3:21 PM		ADC Therapeutics (Filer)
Form DEFA14A
04/16/2024
3:16 PM		ADC Therapeutics (Filer)
Form PRE 14A
04/09/2024
3:06 PM		ADC Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/15/2024
3:11 PM		ADC Therapeutics (Filer)
Form 424B3
03/15/2024
3:11 PM		ADC Therapeutics (Filer)
Form 424B3
03/14/2024
11:15 PM		ADC Therapeutics (Filer)
Form EFFECT
03/14/2024
11:15 PM		ADC Therapeutics (Filer)
Form EFFECT
03/14/2024
11:15 PM		ADC Therapeutics (Filer)
Form EFFECT
03/13/2024
3:17 PM		ADC Therapeutics (Filer)
Form POS AM
03/13/2024
3:14 PM		ADC Therapeutics (Filer)
Form POS AM
03/13/2024
2:19 PM		ADC Therapeutics (Filer)
Form ARS
03/13/2024
11:25 AM		ADC Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/13/2024
6:39 AM		ADC Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/05/2024
8:15 AM		ADC Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/13/2024
8:47 AM		ADC Therapeutics (Subject)
Prosight Management, LP (Filed by)
Form SC 13G/A
02/12/2024
9:13 AM		ADC Therapeutics (Subject)
ASTRAZENECA PLC (Filed by)
ASTRAZENECA PLC (Filed by)
Form SC 13G/A
02/09/2024
8:50 PM		ADC Therapeutics (Issuer)
Green Jeremy (Reporting)
RedCo II Master Fund, L.P. (Reporting)
Redmile Group, LLC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/09/2024
8:45 PM		ADC Therapeutics (Issuer)
Green Jeremy (Reporting)
RedCo II Master Fund, L.P. (Reporting)
Redmile Group, LLC (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
01/24/2024
7:00 AM		ADC Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/19/2024
3:30 PM		ADC Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools

Related Companies
SEC Filings Tools

This page (NYSE:ADCT) was last updated on 1/18/2025 by MarketBeat.com Staff
From Our Partners
Last time you’ll see this priced at $1.00
When was the last time you bought something for a buck? I don’t even think you can buy anything at McDonalds f...
StocksToTrade | Sponsored
HOTTEST TRADER IN AMERICA 🔥🔥🔥
Ready for a rocket ride this weekend? After alerting his readers to a tiny $2 stock called Bright Minds Bio...
Timothy Sykes | Sponsored
Stunning Trump Exec Order Leaked
Most people have no clue this unassuming facility exists. Yet the minute Donald Trump takes office... ...
Banyan Hill Publishing | Sponsored
Bitcoin to $200K?
Newsweek recently asked several analysts whether they think Bitcoin will hit $200,000 by the end of 2025. T...
Stansberry Research | Sponsored
Elon's "Final Move" Could Send This Stock Soaring
Whenever Elon Musk starts a new venture... Early investors get the opportunity to become millionaires... ...
Behind the Markets | Sponsored
The Biggest Money-Making Idea in My 43 Years in the Stock Market
Billionaires and top investors - including the late great Charlie Munger - and many more names you would recog...
The Oxford Club | Sponsored
Do this Before Elon’s Reveal on January 22nd
Elon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but...
Brownstone Research | Sponsored
URGENT: This Altcoin Opportunity Won’t Wait – Act Now
It’s here. This is the moment we’ve been waiting for. The next 3-6 months in crypto will be absolutely life...
Crypto Swap Profits | Sponsored